1 序文
2 範囲と方法論
2.1 本調査の目的
2.2 利害関係者
2.3 データソース
2.3.1 一次情報源
2.3.2 二次情報源
2.4 市場予測
2.4.1 ボトムアップアプローチ
2.4.2 トップダウンアプローチ
2.5 予測手法
3 エグゼクティブサマリー
4 はじめに
4.1 概要
4.2 産業用主要トレンド
5 世界の自動車ボディ・イン・ホワイト市場
5.1 市場概要
5.2 市場実績
5.3 COVID-19 の影響
5.4 市場予測
6 材料タイプ別市場内訳
6.1 アルミニウム
6.1.1 市場動向
6.1.2 市場予測
6.2 鋼鉄
6.2.1 市場動向
6.2.2 市場予測
6.3 複合材料
6.3.1 市場動向
6.3.2 市場予測
6.4 その他
6.4.1 市場動向
6.4.2 市場予測
7 車両タイプ別市場
7.1 乗用車
7.1.1 市場動向
7.1.2 市場予測
7.2 商用車
7.2.1 市場動向
7.2.2 市場予測
8 推進タイプ別市場
8.1 内燃エンジン
8.1.1 市場動向
8.1.2 市場予測
8.2 電気自動車
8.2.1 市場動向
8.2.2 市場予測
9 接合技術別市場
9.1 溶接
9.1.1 市場動向
9.1.2 市場予測
9.2 クリンチング
9.2.1 市場動向
9.2.2 市場予測
9.3 レーザーブレージング
9.3.1 市場動向
9.3.2 市場予測
9.4 接合
9.4.1 市場動向
9.4.2 市場予測
9.5 その他
9.5.1 市場動向
9.5.2 市場予測
10 地域別市場規模
10.1 北米
10.1.1 米国
10.1.1.1 市場動向
10.1.1.2 市場予測
10.1.2 カナダ
10.1.2.1 市場動向
10.1.2.2 市場予測
10.2 アジア太平洋地域
10.2.1 中国
10.2.1.1 市場動向
10.2.1.2 市場予測
10.2.2 日本
10.2.2.1 市場動向
10.2.2.2 市場予測
10.2.3 インド
10.2.3.1 市場動向
10.2.3.2 市場予測
10.2.4 韓国
10.2.4.1 市場動向
10.2.4.2 市場予測
10.2.5 オーストラリア
10.2.5.1 市場動向
10.2.5.2 市場予測
10.2.6 インドネシア
10.2.6.1 市場動向
10.2.6.2 市場予測
10.2.7 その他
10.2.7.1 市場動向
10.2.7.2 市場予測
10.3 欧州
10.3.1 ドイツ
10.3.1.1 市場動向
10.3.1.2 市場予測
10.3.2 フランス
10.3.2.1 市場動向
10.3.2.2 市場予測
10.3.3 英国
10.3.3.1 市場動向
10.3.3.2 市場予測
10.3.4 イタリア
10.3.4.1 市場動向
10.3.4.2 市場予測
10.3.5 スペイン
10.3.5.1 市場動向
10.3.5.2 市場予測
10.3.6 ロシア
10.3.6.1 市場動向
10.3.6.2 市場予測
10.3.7 その他
10.3.7.1 市場動向
10.3.7.2 市場予測
10.4 ラテンアメリカ
10.4.1 ブラジル
10.4.1.1 市場動向
10.4.1.2 市場予測
10.4.2 メキシコ
10.4.2.1 市場動向
10.4.2.2 市場予測
10.4.3 その他
10.4.3.1 市場動向
10.4.3.2 市場予測
10.5 中東およびアフリカ
10.5.1 市場動向
10.5.2 国別の市場内訳
10.5.3 市場予測
11 推進要因、阻害要因、機会
11.1 概要
11.2 推進要因
11.3 阻害要因
11.4 機会
12 バリューチェーン分析
13 ポーターのファイブフォース分析
13.1 概要
13.2 買い手の交渉力
13.3 売り手の交渉力
13.4 競争の度合い
13.5 新規参入の脅威
13.6 代替品の脅威
14 価格分析
15 競合状況
15.1 市場構造
15.2 主要企業
15.3 主要企業のプロフィール
ABB Ltd.
Benteler International AG
CIE Automotive
Dura Automotive Systems
Gestamp Automocion S.A.
Kuka AG
Magna International Inc.
Martinrea International Inc.
Norsk Hydro ASA
Tata Steel Limited
TECOSIM Group
thyssenkrupp AG
Autologous stem cell therapy is a medical procedure in which a patient's stem cells are used to repair damaged tissues and organs or treat various diseases. The procedure involves harvesting stem cells from a patient's body, usually from bone marrow or adipose tissue, and then processing and injecting them back into the body. Non-stem cell-based therapies, on the other hand, involve using cells that are not stem cells, such as immune cells, fibroblasts, and muscle cells, to repair or regenerate damaged tissues or organs. Autologous stem cell therapy is used to treat cardiovascular diseases, neurodegenerative diseases, and autoimmune disorders, while non-stem cell-based therapies are employed in treating chronic wounds, heart disease, and Parkinson's disease.
Autologous Stem Cell and Non-Stem Cell Based Therapies Market Trends:
The growth of the global autologous stem cell and non-stem cell based therapies market is primarily driven by the increasing prevalence of cancer, diabetes, cardiovascular disorders, and neurodegenerative diseases due to smoking, poor diet, and sedentary lifestyles of consumers. Besides this, the rising geriatric population and the growing demand for autologous stem and non-stem cell based therapies are creating a positive outlook for the market. Moreover, the ongoing development of innovative autologous stem cell therapies for regenerative medicine and the widespread demand for personalized therapies are presenting remunerative growth opportunities for the market. In addition to this, the surging popularity of minimally invasive treatments, the expanding acceptance of stem cell therapies, and the implementation of favorable government initiatives, such as financial and regulatory support for stem cell research, are aiding in market expansion. Furthermore, continuous advancements in stem cell technologies have enabled researchers to better control the differentiation of stem cells and develop improved and effective treatments, which, in turn, is acting as a significant growth-inducing factor. Besides this, the bolstering growth of the healthcare sector, extensive research and development (R&D) activities, the escalating health consciousness among consumers, and favorable reimbursement policies are contributing to the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global automotive body-in-white market, along with forecasts at the global, regional, and country levels from 2025-2033. Our report has categorized the market based on the material type, vehicle type, propulsion type, and joining technique.
Type Insights:
Autologous Stem Cells
Autologous Non-Stem Cells
The report has provided a detailed breakup and analysis of the autologous stem cell and non-stem cell based therapies market based on the type. This includes autologous stem cells and autologous non-stem cells. According to the report, autologous stem cells represented the largest segment.
Application Insights:
Cancer
Neurodegenerative Disorders
Cardiovascular Disease
Orthopedic Diseases
Others
A detailed breakup and analysis of the autologous stem cell and non-stem cell based therapies market based on the application has also been provided in the report. This includes cancer, neurodegenerative disorders, cardiovascular disease, orthopedic diseases, and others. According to the report, cancer accounted for the largest market share.
End User Insights:
Hospitals
Ambulatory Surgical Centers
Research Facilities
The report has provided a detailed breakup and analysis of the autologous stem cell and non-stem cell based therapies market based on the end user. This includes hospitals, ambulatory surgical centers, and research facilities. According to the report, hospitals represented the largest segment.
Regional Insights:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for autologous stem cell and non-stem cell based therapies. Some of the factors driving the North America autologous stem cell and non-stem cell based therapies market included the expanding prevalence of chronic diseases, the rising demand for personalized medicines, and continuous advancements in stem cell technologies.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global autologous stem cell and non-stem cell based therapies market. Detailed profiles of all major companies have also been provided. Some of the companies covered include BrainStorm Cell Limited, Cytori Therapeutics Inc., Holostem Terapie Avanzate S.r.l., Lisata Therapeutics, U.S. Stem Cell Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report:
How has the global autologous stem cell and non-stem cell based therapies market performed so far, and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global autologous stem cell and non-stem cell based therapies market?
What is the impact of each driver, restraint, and opportunity on the global autologous stem cell and non-stem cell based therapies market?
What are the key regional markets?
Which countries represent the most attractive autologous stem cell and non-stem cell based therapies market?
What is the breakup of the market based on the type?
Which is the most attractive type in the autologous stem cell and non-stem cell based therapies market?
What is the breakup of the market based on the application?
Which is the most attractive application in the autologous stem cell and non-stem cell based therapies market?
What is the breakup of the market based on the end user?
Which is the most attractive end user in the autologous stem cell and non-stem cell based therapies market?
What is the competitive structure of the global autologous stem cell and non-stem cell based therapies market?
Who are the key players/companies in the global autologous stem cell and non-stem cell based therapies market?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Automotive Body-in-White Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Material Type
6.1 Aluminium
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Steel
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Composites
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Vehicle Type
7.1 Passenger Vehicles
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Commercial Vehicles
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Propulsion Type
8.1 IC Engines
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Electric Vehicles
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by Material Joining Technique
9.1 Welding
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Clinching
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Laser Brazing
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Bonding
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Others
9.5.1 Market Trends
9.5.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 Drivers, Restraints, and Opportunities
11.1 Overview
11.2 Drivers
11.3 Restraints
11.4 Opportunities
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 ABB Ltd.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Benteler International AG
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 CIE Automotive
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.4 Dura Automotive Systems
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5 Gestamp Automoción S.A.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.6 Kuka AG
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Magna International Inc.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Martinrea International Inc.
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.9 Norsk Hydro ASA
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Tata Steel Limited
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 TECOSIM Group
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.12 thyssenkrupp AG
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis
*** 自動車ボディ・イン・ホワイトの世界市場に関するよくある質問(FAQ) ***
・自動車ボディ・イン・ホワイトの世界市場規模は？
→IMARC社は2024年の自動車ボディ・イン・ホワイトの世界市場規模を1008億米ドルと推定しています。
・自動車ボディ・イン・ホワイトの世界市場予測は？
→IMARC社は2033年の自動車ボディ・イン・ホワイトの世界市場規模を1217億米ドルと予測しています。
・自動車ボディ・イン・ホワイト市場の成長率は？
→IMARC社は自動車ボディ・イン・ホワイトの世界市場が2025年～2033年に年平均2.1%成長すると展望しています。
・世界の自動車ボディ・イン・ホワイト市場における主要プレイヤーは？
→「ABB Ltd.、Benteler International AG、CIE Automotive、Dura Automotive Systems、Gestamp Automocion S.A.、Kuka AG、Magna International Inc.、Martinrea International Inc.、Norsk Hydro ASA、Tata Steel Limited、TECOSIM Group、thyssenkrupp AGなど ...」を自動車ボディ・イン・ホワイト市場のグローバル主要プレイヤーとして判断しています。
※上記FAQの市場規模、市場予測、成長率、主要企業に関する情報は本レポートの概要を作成した時点での情報であり、最終レポートの情報と少し異なる場合があります。
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
